Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Vaccine manufacturing is lumpy, supply not as good as hoped, UK says

Mon, 18th Jan 2021 08:16

* UK says AstraZeneca slower than hoped

* UK says Pfizer changes may lead to delays

* UK is vaccinating 140 people per minute on average
(Recasts headline and lead with manufacturing issues)

By Guy Faulconbridge and Kate Holton

LONDON, Jan 18 (Reuters) - Britain's vaccine rollout is
limited by a "lumpy" manufacturing process with production
changes by Pfizer and a delay by AstraZeneca
that could lead to brief supply disruption, Vaccine Deployment
Minister Nadhim Zahawi said on Monday.

The United Kingdom, which has the world's fifth worst
official COVID-19 death toll, is racing to be among the first
major countries to vaccinate its population - seen as the best
way to exit the pandemic and get the economy going again.

The United Kingdom has vaccinated 3,857,266 people with a
first dose and 449,736 with a second dose. On vaccines
administered per 100 people, the United Kingdom is fourth in the
world after Israel, the United Arab Emirates and Bahrain.

Zahawi told LBC radio that the United Kingdom was hoping for
2 million vaccines a week from AstraZeneca but that
those numbers will not be reached until mid February. Still, he
said the UK was on course to hit its rollout targets.

"It's been a bit lumpy," Zahawi said of vaccine manufacture.

Pfizer will temporarily reduce its deliveries to Europe of
its vaccine against COVID-19 while it upgrades its production
capacity.

"There's bound to be delays. Any new manufacturing process
has challenges at the outset, it is lumpy, it begins to
stabilise and get better and better week in, week out," Zahawi
told the BBC.

"The Pfizer BioNTech vaccine is a messenger RNA chemical,
difficult chemical to manufacture, very very challenging but
they're doing really well, they want to do more which is why
they're reconfiguring to add volume to the whole world," Zahawi
said.

"That could delay supply but I'm confident we can meet our
target."

VACCINE HOPES

Mass COVID-19 vaccines are seen as the best way to exit the
pandemic which has killed more than 2 million people, wiped out
trillions of dollars in economic output and upended normal life
for people across the world.

The United Kingdom is vaccinating 140 people per minute
against COVID-19 on average.

"It is going well, we're vaccinating on average 140 people,
that's first jab, literally a minute. That's the average so some
areas are doing better," Zahawi told Sky.

Britain is currently rolling out the vaccine to the most
vulnerable first, starting with those who are in care homes or
over 80 years of age. In areas where a majority of over 80s have
been offered a vaccine, letters are going out to the over 70s
and those who are clinically extremely vulnerable.

Zahawi said a 24-hour vaccine offering would begin to be
piloted in London by the end of the month.

Essential workers such as teachers, the police and shop
assistants could move to the top of the list for a vaccine once
all those over 50 have been offered a shot, Zahawi said.

"Teachers, police officers, shop workers, those who through
no fault of their own other than the work that they do may come
into contact with the virus in much greater volume, should be
top of the list," Zahawi told Times Radio.
(Reporting by Guy Faulconbridge and Kate Holton; editing by
Sarah Young, Paul Sandle and Philippa Fletcher)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.